Reports
Global Xerostomia Treatment Market Size, Share, Growth: By Product: Artificial Saliva, Salivary Stimulants, Saliva Substitutes, Drugs, Salivary Pens, Others; By Type: OTC, Prescription; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online, Others; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
Global Xerostomia Treatment Market Outlook
The global xerostomia treatment market is expected to grow at a CAGR of 3.5 % in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Robust Healthcare System and Awareness Programs in North America to Boost the Market Growth
North America is expected to lead the market for xerostomia treatment, followed by Europe. The major factors governing the market dominance include prominent growth in the number of xerostomia cases as well as other diseases that lead to dry-mouths, such as Sjogren's syndrome, rheumatoid arthritis, and HIV. The large number is also due to the significant geriatric population in these areas. Awareness camps are frequently conducted by various organizations across the US and Canada by the Sjogren's Syndrome Foundation about the disease. Ease of access and availability of healthcare facilities, and robust medical infrastructure with conducive compensation scenarios are some of the important factors, which are helping the market grow in North America. As the Asia-Pacific region is expected to grow at a fast rate during the forecast period, and as healthcare expenditure and awareness about various health conditions improve, the market for xerostomia therapies is expected to grow in these regions. Ailments such as Parkinson’s disease, cancer, diabetes mellitus, are a few of the dry mouth associated diseases. As the awareness of these diseases increases, the market for xerostomia is, in turn, expected to rise over the forecast period.
Xerostomia Treatment: Market Segmentation
Xerostomia, also known as the dry-mouth condition, is a state of lack of saliva production in the mouth. This might also be a consequence of the change in the quality of saliva produced. Normally, it arises due to many different reasons, such as side effects of medicine, dehydration, mouth bleeding, adverse effects of radiation especially due to radiation in surgery, cigarette smoking. Xerostomia is seen as a by-product of other health conditions and is not considered a disease. This condition is majorly observed in the elderly population. Chemotherapy, Sjogren’s Syndrome and HIV are also some of the dry mouth associated diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the industry is segmented into:
- Artificial Saliva
- Salivary Stimulants
- Saliva Substitutes
- Drugs
- Salivary Pens
- Others
By type, the industry is bifurcated into:
- OTC
- Prescription
On the basis of distribution channels, the industry is segregated into:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Cases of Lifestyle Diseases to Boost the Market for Xerostomia Treatment
The increasing consumption and dependence on medication is the major driver for the rise of xerostomia treatment industry. A growing number of cases of Sjogren's syndrome as well as diagnosis of it is also a major driver of this market. Moreover, as the geriatric population is increasing across the globe, coupled with increasing cases of chronic and lifestyle related diseases, the market is expected to enhance during the forecast period. There has been a rising awareness towards the diagnosis of xerostomia in recent years is aiding the market growth. This is expected to boost the market growth in the forecast period as well. Further, the increase in the cases of diseases such as cancer, HIV, and Sjogren’s syndrome drives the demand for radiation and chemotherapy. Xerostomia is a side-effect of these treatments. However, lack of health awareness towards xerostomia in developing countries is expected to decelerate the growth of this market.
Key Industry Players in the Global Xerostomia Treatment Market
The report gives a detailed analysis of the following key players in the global xerostomia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- 3M Co.
- GlaxoSmithKline plc
- Saliwell Ltd
- Sun Pharmaceutical Industries Ltd
- Cumberland Pharmaceuticals Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Type, Distribution Channel, Region |
| Breakup by Product | Artificial Saliva, Salivary Stimulants, Saliva Substitutes, Drugs, Salivary Pens, Others |
| Breakup by Type | OTC, Prescription |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | 3M Co., GlaxoSmithKline plc, Saliwell Ltd, Sun Pharmaceutical Industries Ltd, Cumberland Pharmaceuticals Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Xerostomia Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Xerostomia Treatment Historical Market (2015-2019)
8.3 Global Xerostomia Treatment Market Forecast (2020-2025)
8.4 Global Xerostomia Treatment Market by Product
8.4.1 Artificial Saliva
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2015-2019)
8.4.1.3 Forecast Trend (2020-2025)
8.4.2 Salivary Stimulants
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2015-2019)
8.4.2.3 Forecast Trend (2020-2025)
8.4.3 Saliva Substitutes
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2015-2019)
8.4.3.3 Forecast Trend (2020-2025)
8.4.4 Drugs
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2015-2019)
8.4.4.3 Forecast Trend (2020-2025)
8.4.5 Salivary Pens
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2015-2019)
8.4.5.3 Forecast Trend (2020-2025)
8.4.6 Others
8.5 Global Xerostomia Treatment Market by Type
8.5.1 OTC
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2015-2019)
8.5.1.3 Forecast Trend (2020-2025)
8.5.2 Prescription
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2015-2019)
8.5.2.3 Forecast Trend (2020-2025)
8.6 Global Xerostomia Treatment Market by Distribution Channel
8.6.1 Hospital Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2015-2019)
8.6.1.3 Forecast Trend (2020-2025)
8.6.2 Retail Pharmacies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2015-2019)
8.6.2.3 Forecast Trend (2020-2025)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2015-2019)
8.6.3.3 Forecast Trend (2020-2025)
8.6.4 Others
8.7 Global Xerostomia Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2015-2019)
9.1.2 Forecast Trend (2020-2025)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2015-2019)
9.2.2 Forecast Trend (2020-2025)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2015-2019)
9.3.2 Forecast Trend (2020-2025)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2015-2019)
9.4.2 Forecast Trend (2020-2025)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2015-2019)
9.5.2 Forecast Trend (2020-2025)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 3M Co.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 GlaxoSmithKline plc
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Saliwell Ltd
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Sun Pharmaceutical Industries Ltd
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Cumberland Pharmaceuticals Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Xerostomia Treatment Market: Key Industry Highlights, 2015 and 2025
2. Global Xerostomia Treatment Historical Market: Breakup by Product (USD Billion), 2015-2019
3. Global Xerostomia Treatment Market Forecast: Breakup by Product (USD Billion), 2020-2025
4. Global Xerostomia Treatment Historical Market: Breakup by Type (USD Billion), 2015-2019
5. Global Xerostomia Treatment Market Forecast: Breakup by Type (USD Billion), 2020-2025
6. Global Xerostomia Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2015-2019
7. Global Xerostomia Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2020-2025
8. Global Xerostomia Treatment Historical Market: Breakup by Region (USD Billion), 2015-2019
9. Global Xerostomia Treatment Market Forecast: Breakup by Region (USD Billion), 2020-2025
10. North America Xerostomia Treatment Historical Market: Breakup by Country (USD Billion), 2015-2019
11. North America Xerostomia Treatment Market Forecast: Breakup by Country (USD Billion), 2020-2025
12. Europe Xerostomia Treatment Historical Market: Breakup by Country (USD Billion), 2015-2019
13. Europe Xerostomia Treatment Market Forecast: Breakup by Country (USD Billion), 2020-2025
14. Asia Pacific Xerostomia Treatment Historical Market: Breakup by Country (USD Billion), 2015-2019
15. Asia Pacific Xerostomia Treatment Market Forecast: Breakup by Country (USD Billion), 2020-2025
16. Latin America Xerostomia Treatment Historical Market: Breakup by Country (USD Billion), 2015-2019
17. Latin America Xerostomia Treatment Market Forecast: Breakup by Country (USD Billion), 2020-2025
18. Middle East and Africa Xerostomia Treatment Historical Market: Breakup by Country (USD Billion), 2015-2019
19. Middle East and Africa Xerostomia Treatment Market Forecast: Breakup by Country (USD Billion), 2020-2025
20. Global Xerostomia Treatment Market Structures
Key Questions Answered in the Report
The global xerostomia treatment market is projected to grow at a CAGR of 3.5% between 2024 and 2032.
The major drivers of the market include the rising geriatric population, increasing cases of chronic and lifestyle related diseases, rising awareness towards the diagnosis of xerostomia, increase in the cases of diseases such as cancer, HIV, ease of access and availability of healthcare facilities, and robust medical infrastructure.
The increasing consumption and dependence on medication and a growing number of cases of Sjogren's syndrome as well as its diagnosis are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The products include artificial saliva, salivary stimulants, saliva substitutes, drugs, and salivary pens, among others.
OTC and prescription are the types of xerostomia treatments.
The xerostomia treatment market can be broadly categorised based on its distribution channels into hospital pharmacies, retail pharmacies, and online, among others.
The major players in the industry are 3M Co., GlaxoSmithKline plc, Saliwell Ltd, Sun Pharmaceutical Industries Ltd, and Cumberland Pharmaceuticals Inc., among others.
Analyst Review
The global xerostomia treatment market was driven by the increasing consumption and dependence on medication in the historical period. Aided by the rising geriatric population and growing number of cases of Sjogren's syndrome, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 3.5%.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The products include artificial saliva, salivary stimulants, saliva substitutes, drugs, and salivary pens, among others. OTC and prescription are the types of xerostomia treatments. The xerostomia treatment market can be broadly categorised based on its distribution channels into hospital pharmacies, retail pharmacies, and online, among others. The major regional markets for the xerostomia treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The major players in the industry are 3M Co., GlaxoSmithKline plc, Saliwell Ltd, Sun Pharmaceutical Industries Ltd, and Cumberland Pharmaceuticals Inc., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER